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Materials and Methods 
Details of the model We	developed	a	computational	stochastic	model	of	spatial	tumour	growth	that	allows	simulating	different	strategies	of	multi-region	tissue	sampling	followed	by	synthetic	generation	of	high-throughput	sequencing	data.		We	consider	tumour	cells	as	asexually	reproducing	individuals	that	die	and	divide	with	certain	pre-defined	probabilities.	If	b	is	the	birth	rate	for	each	cell	and	d	the	death	rate,	then	the	growth	of	the	population	over	time	t	is:			 																																							𝑁(𝑡) = 𝑒(()*)+																																																			[1]		where	N(t)	is	a	population	size	at	time	t,	and	b-d	is	the	net	growth	rate.	At	first,	we	assume	that	birth	and	death	rates	are	constant	over	time,	whereas	the	overall	growth	rate	can	vary	over	time	due	to	the	randomness	of	each	birth	or	death	event,	as	well	as	due	to	spatial	constrains	that	can	limit	or	promote	cell	division	over	time.	We	model	spatial	constraints	with	the	boundary	proliferation	parameter	a,	which	models	the	distance	from	the	border	of	the	tumour	within	which	cells	are	allowed	to	proliferate	even	in	the	absence	of	space	(by	pushing	neighbouring	cells	outwards).	When	a~1	all	cells	can	proliferate	(homogeneous	growth),	and	
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their	growth	is	equivalent	to	an	exponential	expansion.	When	a~0,	cells	can	only	proliferate	if	they	have	an	empty	space	in	their	neighbourhood,	resulting	in	only	a	small	layer	of	cells	at	the	tumour	border	being	able	to	divide.	In	this	case	the	growth	curve	can	significantly	deviate	from	equation	[1].		In	addition	to	cell	division,	we	also	model	mutation	and	selection,	where	the	latter	can	change	birth	and/or	death	rates.	We	model	somatic	mutations	acquired	by	each	cell	after	division	as	a	Poisson	random	variable	–	Pois(𝑢),	where	u	is	the	mean	mutation	rate.	Thus,	after	each	cell	division,	a	random	set	of	new	unique	mutations	occur	in	each	cell	of	the	two	cells	resulting	from	the	division.	The	majority	of	these	mutations	are	passenger	mutations	and	hence	do	not	affect	a	cell’s	phenotype.	However,	they	enable	us	to	trace	cell	lineages	uniquely	in	the	final	tumour.	In	addition,	we	also	allow	for	driver	mutation	‘events’	that	can	lead	to	positive	selection	of	a	subpopulation	of	cancer	cells:	a	driver	event	conveys	a	fitness	advantage	to	that	particular	cell	and	its	offspring,	thus	allowing	the	lineage	to	increase	in	frequency.	Since	we	ask	what	is	the	distribution	of	mutations	across	space,	rather	than	the	expected	waiting	time	of	driver	events	as	previously	analysed	[60],	we	introduce	a	driver	mutation	at	a	fixed	time	in	our	simulations,	also	to	make	simulations	comparable	and	computationally	efficient.		To	simulate	tumour	growth	in	space	with	these	four	stochastic	events	–	birth,	death,	mutation	and	selection	–	we	have	used	a	modification	of	the	Gillespie	algorithm	[26].				Specifically,	the	simulation	framework	works	as	follows:		
• Initialization:	start	with	a	2D/3D	grid	with	Von	Neumann	neighbourhood.	Place	the	first	tumour	cell	in	the	centre	of	the	grid.	Set	time	t=0.		Until	a	cell	reaches	a	predefined	grid	boundary,	repeat	the	following	steps		1. Compute	the	reaction	propensities	according	to	the	Gillespie	algorithm.	Each	reaction	event	of	birth	(or	death)	has	a	functional	form	𝑓(𝑥) = 𝑘𝑥;	where	𝑥	is	the	number	of	cells	of	type	“x”	(wild-type	or	mutant),	and	𝑘	is	either	the	birth	or	death	rate.	The	time	of	each	event	is	obtained	by	sampling	an	exponential	random	variable	with	mean	given	by	its	propensity.	The	next	event	chosen	is	the	one	completing	first	(i.e.,	with	the	smallest	clock	value,	as	in	the	so-called	next	reaction	method	[26]).	Given	the	event,	we	increment	the	time	by	its	clock.	Note	that	these	time	steps	do	not	correspond	to	population	doubling	times	i.e.	generations;	doubling	times	can	be	retrieved	scaling	time	by	a	factor	log(2).		2. If	the	next	event	is	a	cell	division,	we	use	a	heuristic	method	to	place	the	2	daughter	cells	on	the	grid.	We	first	replace	the	parent	cell	with	the	first	daughter,	and	search	for	a	suitable	position	to	place	the	second	daughter	cell.	We	use	a	Von	Neumann	neighbourhood	and	check	if	any	of	the	8	(in	2D	grid)	neighbouring	spots	of	the	parent	cell	is	empty;	if	one	or	more	are,	we	locate	the	second	cell	in	one	of	those	spots	at	random.	Otherwise,	with	a	probability	determined	by	a	parameter	𝑎,	we	push	all	cells	along	a	randomly	chosen	direction	until	we	hit	the	grid	boundary,	and	place	the	second	daughter	at	the	nearest	emptied	spot.	With	the	parameter	𝑎	we	can	model	boundary	driven	growth,	as	it	represents	the	fraction	of	the	radius	of	the	growing	tumour	where	cells	are	allowed	to	proliferate;	that	is,		𝑎 = 0.2	creates	a	tumour	periphery	of	width	equal	to	20%	of	the	whole	tumour	width	in	which	cells	are	allowed	to	proliferate	even	without	empty	space	by	pushing	neighbouring	cells	outwards	(when	𝑎 = 1,	periphery	width	is	100%,	every	cell	can	always	push	and	divide,	and	the	tumour	grows	exponentially).	When	a	cell	divides,	we	
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generate	passenger	mutations	by	drawing	a	number	from	Pois(𝑢).	These	mutations	will	be	assigned	to	both	daughter	cells.		3. If	the	next	event	is	cell	death,	we	simply	free	the	position	allocated	to	the	cell.		4. At	the	end	of	this	step,	we	check	if	the	clock	is	greater	than	the	time	of	the	next	scheduled	driver	event	tdriver;	if	it	is,	we	convert	a	single	wild	type	(WT)	cell	into	a	new	mutant	and	increase	its	birth	rate,	or	decrease	its	death	rate.	This	will	result	in	mutant	cells	having	a	proliferative	advantage.	To	quantify	the	effect,	we	define	the	fitness	s	as:	1 + 𝑠	 =	(𝑏𝑖𝑟𝑡ℎ_𝑚𝑢𝑡𝑎𝑛𝑡	– 	𝑑𝑒𝑎𝑡ℎ_𝑚𝑢𝑡𝑎𝑛𝑡)/(𝑏𝑖𝑟𝑡ℎ_𝑤𝑡	– 	𝑑𝑒𝑎𝑡ℎ_𝑤𝑡).		
Details	of	the	data	generation	and	error	modelling.	At	the	end	of	the	simulation,	we	can	collect	bulk	or	single-cells	and	simulate	sequencing	data	generation.	Bulk	Samples	are	spatially	separated	tumour	chunks	‘cut	out’	from	the	tumour.	We	model	two	different	shapes:			 1. Squares,	which	are	referred	to	in	the	paper	as	‘punch	biopsies’		2. Long	thin	rectangles	that	resemble	a	‘needle	biopsy’			A	bulk	sample	is	a	set	of	adjacent	cells	from	the	final	tumour	population.	Each	cell	has	its	unique	ID,	a	position	on	a	grid	and	its	list	of	somatic	mutations.	From	the	sampled	cells	(in	a	bulk)	joined	list	of	mutations	we	can	construct	the	Variant	Allele	Frequency	(VAF)	distribution	as	in	a	real	sequencing	experiment.			To	construct	a	VAF	distribution	from	a	simulated	bulk	tumour	sample,	we	mimic	realistic	next	generation	sequencing	steps,	specifically	sequencing	coverage	and	limits	of	detectability	of	low	frequency	mutations.	We	proceed	as	follows:		 1. We	generate	(dispersed)	coverage	values	for	the	input	mutations	by	sampling	a	coverage	from	a	Poisson	distribution	𝐷~	𝑃𝑜𝑖𝑠𝑠𝑜𝑛(𝜆 = 𝑍)	with	mean	𝜆	equal	to	a	desired	sequencing	depth.	2. Once	we	have	sampled	a	depth	value	𝑘	for	a	mutation,	we	sample	its	frequency	(number	of	reads	with	the	variant	allele)	with	a	Binomial	trial.	We	use	𝑓~Binomial(𝑛, 𝑘)	where	𝑛	is	the	proportion	of	cells	carrying	this	mutation	in	the	sample.		This	procedure	guarantees	that	the	generated	read	counts	reflect	the	proportions	of	mutations	in	the	simulated	tumour.	To	model	limits	of	detection	of	a	mutation,	after	resampling	a	mutation,	we	discard	it	if	the	corresponding	number	of	reads	containing	the	variant	allele	is	less	than	5	(using	the	fixed	coverage	100,	which	accounts	for	a	~0.05	minimum	VAF).			We	also	performed	single	cell	sequencing	taking	either	random	single	cells	across	the	whole	tumour	population,	or	from	spatially	structured	biopsies	(mimicking	bulk	tissue	collection	followed	by	single-cell	isolation).	We	used	the	obtained	single	cells	to	construct	maximum	parsimony	phylogenetic	trees.	In	addition	to	single	cell	sequencing,	we	also	model	genotyping	cells	with	a	given	list	of	mutations,	corresponding	to	targeted	sequencing	of	mutations	found	using	e.g.	exome	or	whole-genome	sequencing.	To	implement	this,	we	take	one	of	the	bulk	samples	as	reference	genotype	and	check	for	the	presence	of	each	individual	mutation	in	a	random	set	of	200	cells.	Similarly,	we	use	the	obtained	genotyped	single	cells	to	infer	phylogenetic	trees	and	check	how	much	the	genotyped	trees	differ	from	the	single	cell	trees.			
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Details of the ABC framework Due	to	the	complexity	captured	by	our	spatial	model	of	tumour	growth,	we	do	not	have	explicit	formulas	for	the	stationary	probabilities	of	the	stochastic	process,	and	hence	cannot	derive	a	likelihood	function.	Thus,	we	have	to	use	likelihood-free	methods	to	perform	statistical	inference	on	the	parameters	and	compute	the	posterior	distribution	of	the	parameters	𝜽.		Here	we	use	Approximate	Bayesian	Computation	(ABC)	[53,61]	to	infer	the	parameters	of	our	model.	ABC	is	based	on	the	idea	of	scanning	a	large	grid	of	plausible	values	for	𝜽,	and	simulating	the	model	many	times	with	such	parameters.	Outputs	of	the	model	are	stored	and	compared	using	a	predefined	set	of	summary	statistics	that	are	initially	evaluated	on	real	data.	We	can	then	rank	sets	of	parameters	that	lead	to	the	generation	of	synthetic	data	that	are	close	to	the	observed	data.	We	can	estimate	a	posterior	distribution	𝑝(𝜽|𝑫)	for	the	model	parameters	𝜽,	using	the	available	data	𝑫	and	the	prior	for	𝜽.	This	method	is	computationally	intensive,	and	requires	running	several	hundred	(ideally	thousands	or	millions)	simulations.	In	our	case	we	have	generated	~74	million	simulations	that	we	use	to	perform	the	inference	step.			There	are	different	approaches	to	implement	ABC,	the	simplest	is	rejection-sampling.	More	advanced	implementations	such	as	ABC	with	Markov	Chain	Monte	Carlo	(MCMC)	can	result	in	significant	increases	in	efficiency.	In	our	paper	we	implemented	a	simple	rejection-sampling	algorithm	first,	and	then	added	Monte	Carlo	simulation	techniques	to	speed	up	convergence.	The	simple	ABC	rejection-sampling	algorithm	consists	of	the	following	steps:		1. Sample	parameter	vector	𝜽	from	a	prior	distribution	𝑝(𝜽).	2. Run	the	model	with	the	given	parameter	set	and	generate	the	synthetic	dataset	3. Evaluate	the	distance	between	the	simulated	dataset	and	the	target	data	4. If	the	distance	is	less	than	a	desired	threshold,	accept	the	parameters.	5. Return	to	step	1	and	repeat	until	𝑁	parameter	values	are	accepted.		In	this	study	we	use	uniform	priors	for	all	parameters:	u~Uniform(0, 100), s,d,a~Uniform(0, 1), 
tdriver~Uniform(0, 15). One	of	the	most	important	factors	that	affect	the	ABC	outcome	is	the	number	of	simulations	that	one	can	afford	to	run,	and	the	summary	statistics	were	chosen	to	evaluate	the	distance	between	a	target	and	a	simulated	dataset.	Summary	statistics	can	be	any	quantitative	measurement	that	captures	the	information	from	the	multidimensional	data	without	losing	too	much	information.	As	for	our	distance	metric,	we	use	Euclidean	and	Wasserstein	distances	between	summary	statistics	for	different	parameters	as	discussed	below.			Wasserstein	metric	estimates	the	distance	between	probability	distributions	by	treating	each	distribution	as	a	unit	amount	of	dirt	piled	up	on	a	given	metric	space	and	calculates	the	minimum	cost	required	to	convert	one	pile	into	another.	If	x	and	y	are	two	vectors	we	want	to	evaluate	the	distance	of,	first	we	calculate	their	empirical	distribution	functions	𝐹(𝑡) =∑ 𝑤[(\)𝕝{𝑥[	 ≤ 𝑡}a[bc 	and	𝐺(𝑡) = ∑ 𝑤[(e)𝕝{𝑦[	 ≤ 𝑡}g[bc 	(for	weights	𝑤[\ 	and	𝑤[e	we	took	1/𝑚	and	1/𝑛	respectively),	the	Wasserstein	distance	is	defined	by	evaluating	the	following:			 𝑊i(𝐹, 𝐺) =	= (j |𝐹)c(𝑢) − 𝐺)c(𝑢)|icl )c/i		
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where	we	took	p=1	for	our	analysis.	We	used	the	R	package	transport	(https://CRAN.R-project.org/package=transport)	to	implement	the	distance	calculation.		We	used	different	summary	statistics	for	each	sampling	scheme.	For	punch,	needle	biopsy	and	the	whole	tumour	sampling	–	we	used	the	VAF	distribution	to	compute	our	summary	statistics.	For	the	whole	tumour	VAFs,	our	ABC	procedure	was	similar	to	the	one	in	ref	[25].	For	the	bulk	samples,	since	our	model	implements	multi-region	sampling,	we	first	evaluate	the	multivariate	VAF	distribution	(which	is	a	joint	probability	distribution	of	all	sampled	bulk	VAFs)	and	then	calculated	the	Euclidean	distance	between	the	obtained	empirical	probability	distribution	vectors:		 𝐷mnop[*qrg(𝐹s[a_*r+r(𝑉𝐴𝐹(npvc,… , 𝑉𝐴𝐹(npvx), 𝐹+ryzq+_*r+r(𝑉𝐴𝐹(npvc,… , 𝑉𝐴𝐹(npvx), )		With	single	cell	samples,	we	constructed	phylogenetic	trees	per	tumour	and	used	different	tree-based	summary	statistics	to	evaluate	the	distance.	Since	the	inferred	phylogenetic	tree	branch	length	is	proportional	to	the	number	of	unique	mutations	belonging	to	a	node,	we	decided	to	compare	the	vectors	of	all	branch	lengths	(between	a	simulated	and	target	tumour	trees)	by	computing	the	Wasserstein	distance.	For	the	subclone	introduction	time	tdriver,	death	rate	𝑑	and	the	boundary	driven	growth	parameter	𝑎,	we	chose	to	compare	the	vectors	of	branching	times	for	each	node	of	the	phylogenetic	trees.			Due	to	computational	costs,	we	are	limited	to	run	the	ABC	framework	with	a	small	tumour	size	(~100k	cells)	or	simulate	smaller	datasets	per	inference,	both	of	which	can	significantly	affect	the	outcome.	To	therefore	speed	up	our	ABC	framework	we	implemented	a	Sequential	Monte	Carlo	(SMC)	algorithm	to	increase	the	acceptance	rate	of	the	simple	ABC	rejection	algorithm.	Our	ABC	SMC	algorithm	uses	sequential	importance	sampling	by	running	several	rounds	of	resampling	around	the	accepted	parameters	(correlating	the	rounds),	and	gradually	decreasing	the	acceptance	threshold	while	converging	to	the	posterior	distribution.	This	approach	significantly	increases	the	acceptance	rate	of	the	simulated	datasets	[62].			Our	implementation	of	the	ABC	SMC	algorithm	is	as	follows:		1. Initialise	the	indicator	to	rounds	𝑟	and	the	acceptance	threshold	𝜀	2. If	𝑟 = 1	2.1. Run	the	simple	ABC	rejection	algorithm	(described	above).	2.2. Order	the	simulated	parameters	set	according	to	their	corresponding	distance	values.	2.3. Keep	the	top	Q	per	cent	of	the	parameters.	3. Else	3.1. Sample	next	particle	𝜃 = (𝑢, 𝑡, 𝑠, 𝑑, 𝑎)	from	the	accepted	set	of	parameters	from	round	𝑟 − 1	with	weights	𝑊y)c.	3.2. Perturb	each	sampled	parameter	𝑝[ 	using	uniform	perturbation	kernel			𝐾 = 𝑈𝑛𝑖𝑓(𝑝[ − 𝜎, 𝑝[ + 𝜎),			where	𝜎 = c (max(𝑝[y)c) − min	(𝑝[yc)).	3.3. If	𝜋(𝜃) > 0	,	keep	𝜃	
Else	go	to	step	3.2.	3.4. Simulate	data	from	the	model	using	the	sampled	particle	𝜃.	3.5. Calculate	distance	D	between	the	target	and	the	simulated	data.	3.6. If	𝐷 < 𝜀	,	keep	𝜃	
Else	go	to	step	3.1.	4. Calculate	the	weights	for	all	accepted	particles	1 ≤ 𝑗 ≤ 𝑁:	4.1. If	𝑟 = 1,	set	𝑊(,y) = 1	4.2. Else			
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𝑊(,y) = 𝜋𝜃(,y)∑ 𝑊(p,y)c)𝐾𝜃(p,y)𝜃(p,y)c)xpbc 		5. Update	the	threshold	𝜀	to	the	top	Q-th	percentile	of	the	accepted	particles.	6. Repeat	until	𝜀	is	less	than	a	desired	convergence	threshold.			Our	ABC-SMC	framework	tries	to	recover	all	the	parameters	(referred	to	as	a	particle	in	the	algorithm	above)	at	the	same	time.	We	notice	that	once	one	of	the	parameters	converges,	the	acceptance	rate	decreases	significantly.	We	then	decided	to	fix	the	converged	parameter	at	the	inferred	value	(mode	of	its	posterior)	and	rerun	the	inference	varying	the	rest	of	the	parameters	until	other	parameters	converge,	and	repeat	the	procedure.	We	found	that	this	significantly	improved	the	convergence	speed.	For	the	2D	inference	in	Figure	6	we	started	with	N=100	simulated	particles,	performed	r=10	rounds	with	quantile	Q=0.5,	leading	to	~200k	simulations	for	each	parameter	and	~1M	simulations	in	total.	For	the	3D	inference	in	Figure	S15	we	started	with	N=1000	simulated	particles,	performed	r=10	rounds	with	quantile	Q=0.5,	leading	to	~2M	simulations	for	each	parameter	and	~10M	simulations	in	total.			
Input data format 	The	package	implements	three	sampling	strategies	for	the	inference:		1.	Bulk	samples	(punch	or	needle	biopsies)	-	ABCSMCwithBulkSamples()		2.	Single	cell	sample	phylogenetic	trees	-	ABCSMCwithTreeSampleBL()	and	ABCSMCwithTreeSampleBT()	(using	Branch	Lengths	or	Branching	Times	as	summary	statistics)		3.	Whole	tumour	bulk	sample	-	ABCSMCwithWholeTumour()		Depending	on	the	strategy,	a	user	would	need	to	provide	real	or	synthetic	target	data	in	the	form	of	tumour	bulk	sample	VAFs	(list	of	R	data.frames	where	each	row	should	correspond	to	a	unique	mutation	with	the	following	columns:	clone	(Clone	type	label	set	to	0),	alt	(Number	of	reads	with	the	variant),	depth	(Sequencing	depth),	id	(Unique	mutation	ID)),	an	array	of	whole	tumour	sample	VAFs	or	single	cell	sampling	phylogenetic	trees.	Alternatively,	a	user	can	provide	a	set	of	parameters	(please	refer	to	the	package	documentation	for	the	details	of	each	input	parameter	format)	to	simulate	a	synthetic	target	tumour	to	then	recover	these	input	parameters.				The	functions	output	sequence	of	files	containing	sets	of	inferred	parameters	corresponding	to	each	SMC	round	(that	can	then	be	used	to	construct	the	posterior	distributions	for	each	parameter).	






Code and Simulations Availability The	code	for	our	spatial	model	of	tumour	growth	called	CHESS	(Cancer	Heterogeneity	with	Spatial	Simulations)	is	now	available	in	https://github.com/kchkhaidze/CHESS.cpp.	The	simulation	data	used	to	generate	the	figures	in	this	manuscript	and	perform	statistical	inference	is	available	in	https://github.com/kchkhaidze/chkhaidze_et_al_2019_figures.	
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Figure Legends 	
Figure	S1.	Growth	curves.	Tumour	cell	population	growth	curves	for	each	of	the	representative	cases:	(A)	neutral	homogeneous,	(B)	selective	homogeneous,	(C)	neutral	boundary	driven,	(D)	selective	boundary	driven.	Wild	type	(WT)	and	mutant	growth	curves	are	plotted	separately	in	addition	to	the	whole	population	growth	curves.	Without	the	spatial	constraints	of	our	model,	the	growth	curves	are	exponential	as	expected.	(A,	B)	With	the	boundary	driven	growth	the	growth	becomes	polynomial.	We	can	also	see	for	the	tumours	with	selection	(B,	D)	how	the	mutant	subpopulation	outcompetes	wild	type	cell	population.		
Figure	S2.	Examples	where	selection	is	modelled	by	varying	death	rates	instead	of	birth	
rates,	and	neutral	growth	under	high	cell	death.	Two	examples	where	fitness	advantage	is	modelled	by	decreasing	cell	death	the	mutant	subpopulations	and	increasing	for	the	wild	type.	(A)	The	death	rate	of	the	mutant	subpopulation	is	0.2	while	for	the	WT	is	0.8.	(B)	The	death	rate	of	the	mutant	subpopulation	is	0.3	while	for	the	WT	is	0.9.	(C-F)	Examples	of	neutral	growth	with	high	cell	death,	which	increases	the	level	of	genetic	drift	(especially	noticeable	in	(F))	as	well	as	the	level	of	spatial	intermixing	due	to	stochasticity	of	cell	replacement.	Birth	rate	b	was	1	in	all	simulations.	
Figure	S3.	Mutational	load	comparison	for	different	growth	cases.	(A)	We	sample	each	representative	example	tumours	(T1	–	neutral	homogenous,	T2	–	selective	homogenous,	T3	–	neutral	boundary	driven,	T4	–	selective	boundary	driven)	from	the	tumour	centre	(bulk	sample	C1)	towards	the	periphery	following	the	concentric	circles	in	four	directions:	W	–	west,	E	–	east,	N	–	north,	S	–	south.	The	bulk	indexes	(2W,	3W,	4W)	are	proportional	to	the	distance	from	the	centre	to	the	periphery.	(B)	We	observe	how	the	number	of	mutations	per	bulk	sample	increases	proportionally	to	the	distance	from	the	tumour	centre	in	the	case	of	boundary	driven	growth.	Also,	the	total	number	of	mutations	is	much	higher	for	the	constrained	boundary	driven	growth	than	for	the	homogenous	tumour	due	to	increased	cell	turnover	in	the	former	case.		
	
Figure	S4.	Example	of	imprisonment.	Example	of	selective	boundary	driven	growth	when	the	driver	mutant	subpopulation	gets	trapped	within	the	wild	type	population	despite	being	fitter	than	the	WT	clone.	
	
Figure	S5.	The	effect	of	stochasticity	and	sampling	bias	on	the	shapes	of	VAF	
distributions	for	the	four	representative	scenarios.	For	each	of	the	representative	cases:	
(A)	neutral	homogeneous,	(B)	selective	homogeneous,	(C)	neutral	boundary	driven,	(D)	selective	boundary	driven,	we	simulated	100	different	runs	of	each	case	keeping	the	underlying	parameters	constant	and	varying	only	the	random	seed	of	the	simulation.	For	each	simulated	tumour,	we	constructed	needle	and	punch	biopsy	sample	VAF	distributions	along	with	the	whole	tumour	VAFs.	Overall	there	is	a	less	variation	among	the	distributions	for	
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neutral	(A,C)	versus	selective	(B,D)	cases.	In	addition,	punch	biopsy	VAFs	scatter	more	than	needle	biopsy	samples	in	comparison	to	the	whole	tumour	VAF	distributions.	(E)	We	separated	the	VAF	distributions	for	the	selective	boundary	driven	between	cases	where	the	new	clone	escaped	and	grew	to	fixation,	versus	escaped	by	not	yet	fixed	(signature	of	ongoing	subclonal	selection),	versus	imprisoned	(leading	to	neutral	dynamics)	
Figure	S6.	Distribution	of	AUC	based	neutrality	test	p-values.	(A)	We	simulate	100	different	tumours	for	each	4	representative	growth	models	and	fit	1/f	test	to	their	corresponding	whole	tumour	sample	VAFs.	Reported	are	the	distributions	of	p-values	obtained	from	each	test	using	the	AUC	statistics.	(B)	For	the	cases	of	boundary-driven	growth	modes	we	compared	tests	of	neutrality	using	the	whole-tumour	sample	versus	punch/needle	biopsies.	
Figure	S7.	Example	of	selection	when	mutant	subpopulation	has	higher	push	power	
instead	than	higher	birth	rate.	Example	of	a	selective	exponential	growth	when	the	mutant	subpopulation	has	higher	‘push	power’	than	the	wild	type	population.		
Figure	S8.	Killing	99%	of	the	cell	population	and	re-growing	tumours.	For	each	of	the	representative	cases:	(A)	neutral	homogeneous,	(B)	selective	homogeneous,	(C)	neutral	boundary	driven,	(D)	selective	boundary	driven,	we	simulated	procedures	of	removing	large	cell	population	(here	99%)	by	the	end	of	tumour	growth	and	wait	for	it	to	regrow	to	its	original	size.	
Figure	S9.	Growth	curves	through	cell	killing.	Tumour	cell	population	growth	curves	for	each	of	the	representative	cases:	(A)	neutral	homogeneous,	(B)	selective	homogeneous,	(C)	neutral	boundary	driven,	(D)	selective	boundary	driven,	where	by	the	end	of	tumour	growth	we	remove	99%	of	the	cell	population	and	wait	for	the	tumour	to	regrow	to	its	original	size.	
Figure	S10.	Allele	frequency	distributions	derived	from	single	cell	sequencing.	We	construct	the	allele	frequency	distributions	from	sequencing	the	randomly	sampled	400	single	cells	(same	as	in	Figure	4)	from	the	four	representative	tumour	examples:	T1	–	neutral	homogenous,	T2	–	selective	homogenous,	T3	–	neutral	boundary	driven,	T4	–	selective	boundary	driven.		
Figure	S11.	Distribution	of	Moran’s	test	effect	size.	We	simulate	100	different	tumours	for	each	4	representative	growth	models	and	test	intermixing	of	subpopulations	within	each	simulation	lattice	using	Moran’s	entropy-based	test.	Each	individual	test	output	significant	p-values	indicating	to	high	spatial	correlation	between	tumour	cell	types	(mutant	vs	WT)	and	their	location	on	tumour	lattice.	Although	the	test	effect	size	(the	observed	values	of	the	Moran’s	test	statistic)	differ	as	we	can	see	from	their	distributions	per	model	scenario.	The	median	values	of	each	observed	statistics	are	reported	at	the	bottom	of	each	violin	plot.	
Figure	S12.	Comparing	the	site	frequency	spectrum	and	phylogenetic	tree	balance	
index	statistics	for	each	representative	scenario	and	sampling	strategy.	(A)	Distributions	of	different	summary	statistics	from	single	cell	sampling	(100x)	phylogenetic	trees	for	the	four	representative	cases.	The	balance	index-based	statistics	(sackin,	colless	with	their	different	normalisation	approaches	–	Yule,	PDA)	seem	to	have	similar	shapes	among	all	four	tumour	cases,	while	tip	and	node	Cophenetic	distance-based	statistics	show	different	trends	for	neutral	versus	selective	examples	with	not	observable	variation	between	homogenous	and	boundary	driven	tumours.	Branch	length-based	statistics	give	similar	results	as	cophenetic	distances.	Only	one	statistic,	maximum	node	depth,	tend	to	have	longer	
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flat	tails	for	boundary	driven	tumours	compared	to	homogenous	tumour	simulations.	(B)	For	each	of	four	tumour	examples,	we	compare	the	total	number	of	passenger	mutations	and	final	population	sizes	along	with	the	time	the	simulations	finish	and	the	final	frequency	of	the	new	sub-population	(introduced	after	a	driver	event).				
Figure	S13.	Posterior	distributions	of	model	parameters	from	each	synthetic	tumour.	The	violin	plots	of	the	posterior	distributions	for	each	model	parameter	per	synthetic	tumour	inferred	by	our	ABC-SMC	framework.	The	three	sets	of	tumours	corresponding	to	the	three	tumour	growth	scenarios	are	plotted	separately:	exponential	(A),	death	(B)	and	boundary	driven	(C).	The	number	on	the	violin	plots	is	the	target	value	of	each	parameter.		
Figure	S14.	The	effect	of	stochasticity	on	the	dependence	of	t	and	s	parameter	
combinations	on	the	VAF	distribution.	To	explore	the	interdependence	of	the	parameter	pair	t	and	s,	for	their	different	values	we	simulate	tumour	growth	while	fixing	all	the	other	parameters	(2D	grid	size=400,	u=10,	d=0,	a=1).	We	summarised	the	obtained	tumours	by	calculating	either	the	Euclidean	norm	of	the	obtained	whole	tumour	VAFs	(C,	D)	or	the	calculating	Euclidean	distance	between	the	cumulative	VAF	distributions	of	the	simulated	and	a	chosen	target	tumour	(in	this	case	target	tumour	parameters	are	t=7,	s=3)	(A,	B).	To	reduce	the	effect	of	stochasticity	we	fix	the	random	seed	in	(B)	and	(D)	and	they	indeed	showed	less	scattered	patterns	of	(A)	and	(C)	plots	respectively.		
Figure	S15.	Posterior	distributions	for	a	3D	model.	ABC	SMC	inference	for	a	selective	homogenous	growth	simulation	in	3D	space.	Real	‘target’	values	are	reported	as	dashed	lines.	We	run	this	ABC	framework	similarly	to	2D	simulations,	where	we	recover	each	parameter	at	a	time;	first	varying	all	parameters,	once	one	is	converged,	fixing	it	at	its	inferred	value	and	rerunning	the	simulation	varying	the	parameters	left	to	infer.	Here	we	first	recovered	mutation	rate,	then	time	and	selective	advantage	(together),	and	finally	death	rate	and	aggression	(together	as	well).	Similar	to	2D	models,	our	ABC	framework	with	whole	tumour	sampling	performs	the	best	compared	to	other	sampling	strategies.	
Table Legends 	
Table	S1.	Parameters	of	the	set	of	synthetic	tumours	used	to	test	the	ABC	inference	
framework.	
Table	S2.	Prior	parameter	ranges	used	for	the	synthetic	ABC	inference	testing.	 
